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The pancreas is an unusual location for metastases from other primary cancers. Rarely, pancreatic metastases from kidney or
colorectalcancershavebeenreported.However,avarietyofothercancersmayalsospreadtothepancreas.Wereportanexceptional
case of pancreatic metastasis from prostate cancer. Diﬀerences in management between primary and secondary pancreatic tumors
make recognition of metastases to the pancreas an objective of ﬁrst importance. Knowledge of unusual locations for metastatic
spread will reduce diagnostic delay and lead to a timely delivery of an appropriate treatment.
1.Introduction
The pancreas is an unusual location for metastases from
other primary cancers. Rarely, pancreatic metastases from
kidney or colorectal cancers have been reported [1]. How-
ever, a variety of other cancers may also spread to the
pancreas. We report an exceptional case of pancreatic
metastasis from prostate cancer.
2. Case Presentation
In August 2009, a 70-year-old man presented in the Emer-
gency Unit with an acute cholestasis and decrease in general
health status. He had a previous history of hormone
refractory, high-grade prostate adenocarcinoma with bone
metastases as ﬁrst presentation (May 2007). The disease
had progressed after endocrine therapy, then after ﬁrst-
line chemotherapy with docetaxel. The patient was cur-
rently treated with diethylstilbestrol. Physical examination
showed marked icterus with no other clinical abnor-
malities. The liver was not palpable. Biological analysis
revealed an important elevation of bilirubin (total bilirubin:
336µmol/L, conjugated bilirubin: 171µmol/L) and alkaline
phosphatase (1.5N). Gamma-glutamyl transferase remained
within the normal range. Serum Prostatic-Speciﬁc Antigen
(PSA) remained unchanged (259ng/mL versus 283ng/mL
one month earlier). Abdominal echography and computed
tomography showed a dilatation of intrahepatic bile duct,
but no obvious tumor of the pancreas. The common bile
duct was also dilated until pancreatic head, but no tumoral
or lithiasic obstruction could be evidenced. There was no
ascites. An MRI was performed, showing a heterogeneous
increase of volume of the pancreas head so as hypertrophic
retro-peritoneal nodes. The ultrasound endoscopy demon-
strated a heterogenic mass that inﬁltrated the pancreatic
head.
Endosonographicﬁne-needlebiopsyandendoscopicret-
rograde cholangiopancreatography (ERCP) were performed.
Histological examination of this inﬁltration revealed the
presence of a metastasis from an undiﬀerentiated carci-
noma, with positive immunohistochemical staining for PSA,
supporting the diagnosis of a pancreatic metastasis from
a metastatic prostate adenocarcinoma. Due to poor per-
formance status, symptomatic treatment only was decided.
Unfortunately, the patient died in October 2009 from disease
progression.
3. Discussion
The main site of metastasis in prostatic adenocarcinoma is
the bone. Most atypical prostate carcinoma metastases are2 Case Reports in Medicine
encountered in the presence of known advanced disease.
Rarely, unusual metastases can be the only sign of distant
spread or a presenting feature of cancer [2]. Pancreas may
constitute a metastatic site for other primary tumors, such
as kidney, colon, stomach, melanoma, or ovarian [1]. To
our knowledge, only two cases of pancreatic metastasis from
prostate cancer have been previously reported [3, 4]. This
suggests that pancreatic tumors in patients with a history
of nonpancreatic malignancy should be always considered
to be a potential metastatic lesion at an unusual site. If
feasible, pathological conﬁrmation should be performed
becausepancreaticmetastasesmayclinicallyorradiologically
mimic a pancreatic primary tumour. Although the diﬀer-
ential diagnosis between a primary pancreatic cancer and
metastases of other adenocarcinomas may be complex, using
commonpathologicalandimmunohistochemicaltechniques
may provide relevant information. In selected patients,
surgical extirpation of isolated metastases to the pancreas
from various primary tumors may potentially improve
outcome [5].
4. Conclusion
Diﬀerences in management between primary and secondary
pancreatic tumors make recognition of metastases to the
pancreas an objective of ﬁrst importance [1]. Knowledge
of unusual locations for metastatic spread will reduce diag-
nostic delay and lead to a timely delivery of an appropriate
treatment.
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